Total Payments
$58,606
2024 Payments
$49,874
Companies
29
Transactions
537
Medicare Patients
290
Medicare Billing
$203,015
Payment Breakdown by Category
Other$40,280 (68.7%)
Food & Beverage$10,451 (17.8%)
Travel$7,815 (13.3%)
Gifts$42.11 (0.1%)
Education$17.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,280 | 10 | 68.7% |
| Food and Beverage | $10,451 | 498 | 17.8% |
| Travel and Lodging | $7,815 | 22 | 13.3% |
| Gift | $42.11 | 3 | 0.1% |
| Education | $17.96 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $51,229 | 128 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,697 | 71 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $1,450 | 74 | $0 (2020) |
| Allergan Inc. | $603.95 | 57 | $0 (2019) |
| Lundbeck LLC | $486.84 | 37 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $393.12 | 13 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $384.57 | 11 | $0 (2019) |
| Alkermes, Inc. | $353.62 | 21 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $278.21 | 19 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $260.72 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,874 | 64 | Janssen Pharmaceuticals, Inc ($49,844) |
| 2023 | $554.20 | 10 | Janssen Pharmaceuticals, Inc ($438.47) |
| 2022 | $198.40 | 11 | Janssen Pharmaceuticals, Inc ($149.31) |
| 2021 | $236.57 | 21 | Janssen Pharmaceuticals, Inc ($128.51) |
| 2020 | $234.51 | 9 | Sunovion Pharmaceuticals Inc. ($167.35) |
| 2019 | $1,659 | 82 | Sunovion Pharmaceuticals Inc. ($606.21) |
| 2018 | $2,932 | 171 | Sunovion Pharmaceuticals Inc. ($602.97) |
| 2017 | $2,918 | 169 | Otsuka America Pharmaceutical, Inc. ($626.80) |
All Payment Transactions
537 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,560.00 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $100.24 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $151.58 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $1,220.02 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $123.61 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $313.47 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $11.00 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $942.97 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $102.00 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $208.19 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Neuroscience | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $95.39 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $254.34 | General |
| Category: Neuroscience | ||||||
| 09/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Neuroscience | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $170.53 | General |
| Category: Neuroscience | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Neuroscience | ||||||
| 08/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $192.18 | General |
| Category: Neuroscience | ||||||
| 08/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $358.46 | General |
| Category: Neuroscience | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $189.85 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 58 | 491 | $337,330 | $43,394 |
| 2022 | 2 | 34 | 123 | $119,850 | $14,293 |
| 2021 | 4 | 83 | 550 | $514,405 | $59,067 |
| 2020 | 5 | 115 | 782 | $311,625 | $86,261 |
Total Patients
290
Total Services
1,946
Medicare Billing
$203,015
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 32 | 290 | $316,100 | $33,731 | 10.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 41 | $13,230 | $5,681 | 42.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 160 | $8,000 | $3,983 | 49.8% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 23 | 105 | $114,450 | $11,728 | 10.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 18 | $5,400 | $2,566 | 47.5% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 43 | 491 | $466,190 | $53,927 | 11.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 31 | $6,975 | $1,968 | 28.2% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), initial delivery and management | Office | 2021 | 12 | 12 | $18,100 | $1,613 | 8.9% |
| 90869 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent motor threshold re-determination with delivery and management | Office | 2021 | 12 | 16 | $23,140 | $1,559 | 6.7% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 32 | 660 | $264,000 | $75,302 | 28.5% |
| 90869 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 22 | 30 | $19,500 | $3,471 | 17.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 59 | $13,275 | $3,382 | 25.5% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 21 | 22 | $12,100 | $3,014 | 24.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 11 | 11 | $2,750 | $1,092 | 39.7% |
About Dr. Steven Harvey, M.D
Dr. Steven Harvey, M.D is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811007289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Harvey, M.D has received a total of $58,606 in payments from pharmaceutical and medical device companies, with $49,874 received in 2024. These payments were reported across 537 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($40,280).
As a Medicare-enrolled provider, Harvey has provided services to 290 Medicare beneficiaries, totaling 1,946 services with total Medicare billing of $203,015. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saint Louis, MO
- Active Since 08/30/2006
- Last Updated 12/17/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1811007289
Products in Payments
- SPRAVATO (Drug) $50,723
- LATUDA (Drug) $1,697
- REXULTI (Drug) $1,406
- VRAYLAR (Drug) $576.42
- INGREZZA (Drug) $384.57
- AUSTEDO (Drug) $373.22
- INVEGA SUSTENNA (Drug) $349.49
- Vivitrol 380 mg (Drug) $304.62
- Fanapt (Drug) $278.21
- Trintellix (Drug) $244.34
- ABILIFY MAINTENA (Drug) $204.23
- Adzenys XR-ODT (Drug) $195.72
- TRINTELLIX (Drug) $193.27
- Evekeo (Drug) $181.01
- CHANTIX (Drug) $167.78
- INVEGA TRINZA (Drug) $156.77
- Auvelity (Drug) $115.73
- MYDAYIS (Drug) $107.80
- NUEDEXTA (Drug) $93.37
- VYVANSE (Drug) $89.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Louis
Dr. Mohd Malik, M.d, M.D
Psychiatry — Payments: $1.8M
Psychiatry $1.8M
Adam Sky, Md, MD
Psychiatry — Payments: $1.4M
Psychiatry $1.4M
Dr. Junaid Syed, M.d, M.D
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Michael Stotler, Md, MD
Psychiatry — Payments: $299,451
Psychiatry $299,451
Dr. Naji Chaaya Salloum, M.d, M.D
Psychiatry — Payments: $236,374
Psychiatry $236,374
Dr. Devnandini Rastogi, Md, MD
Psychiatry — Payments: $230,240
Psychiatry $230,240